Industry

The proposed combination will create a differentiated global biosimilars platform that leverages Kashiv BioSciences’ development and manufacturing capabilities with Amneal Pharmaceuticals’ commercial strengths Complementary acquisition will accelerate biosimilar pipeline and strengthen U.S. commercial position for affordable medicines PISCATAWAY, N.J.–(BUSINESS WIRE)–Kashiv BioSciences, LLC (“Kashiv”), today announced that it has entered into a definitive agreement to be … [Read more…]

Study of CAL101, which targets a novel upstream pathway implicated in fibrotic disease, enrolls 161 patients more than six months ahead of plan; topline data expected Q1 2027 Drug candidate, a monoclonal antibody which targets S100A4, a novel upstream pathway implicated in fibrotic disease, aims to preserve lung function in IPF patients OSLO, Norway & … [Read more…]

New Clinic Brings Advanced Scoliosis and Hyperkyphosis Care to the Local Community BISMARCK, N.D.–(BUSINESS WIRE)–People across North Dakota now have greater access to specialized, non-surgical scoliosis and hyperkyphosis care following the opening of ScoliCare North Dakota. This new clinic delivers a patient-centered approach to scoliosis management, combining advanced technology with expert clinical care to improve … [Read more…]

STK-012 + pembrolizumab + chemotherapy in first‑line non‑squamous NSCLC demonstrated a 50% ORR in predominantly PD‑L1-negative patients 61% ORR with the regimen in patients with at least one mutation in the STK11, KEAP1, or SMARCA4 tumor suppressor genes 50% ORR, PFS 5.5 months, and 88% 6-month OS with the regimen in patients with STK11/KEAP1 co‑mutated … [Read more…]

New Solutions-as-a-Service arm of Simplify Group™ combines a connected AI platform, agentic automation, and deep payer operations expertise to deliver managed outcomes, enabling health plans to replace the complexity tax with accountable results AURORA, Ill.–(BUSINESS WIRE)–#HealthTech—Simplify Group™ today announced the launch of Simplify Alpha™, a Solutions-as-a-Service (SolaaS) company that delivers managed outcomes across payer operations … [Read more…]

BLOOMINGTON, Minn.–(BUSINESS WIRE)–HealthPartners: What: HealthPartners 2026 Annual Meeting (livestreamed) Why it matters: HealthPartners leaders will share an open, year‑in‑review look at organizational performance, financial stewardship and future priorities, including how the nonprofit system is responding to rising costs, growing care complexity and continued change across the health care industry. Who: Andrea Walsh, president and CEO, … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, announced today that it will host a conference call and webcast to discuss its first quarter 2026 financial results on Tuesday, May 5, 2026. The Company’s financial results for the first quarter 2026, ended March 31, 2026, will be … [Read more…]

RAHWAY, N.J. & NUTLEY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 LITESPARK-012 trial evaluating combination regimens for the first-line treatment of patients with advanced clear cell renal cell carcinoma (RCC). The trial evaluated the triplet therapy of KEYTRUDA® … [Read more…]

Initiative brings Proximie’s vision of real-time, agentic OR intelligence, with NVIDIA collaboration powering the next generation of AI for healthcare BOSTON–(BUSINESS WIRE)–Proximie, the operating system for intelligent operating rooms (ORs), is building upon NVIDIA’s foundation models and accelerated platform to power its Smart OR platform, while contributing real-world surgical data and insights that help inform … [Read more…]

Filing acceptance based on Phase III ALLEGORY data for Gazyva showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE) If approved, Gazyva would be the first anti-CD20 therapy to directly target B cells in SLE, potentially becoming the new standard of care for this condition SLE is … [Read more…]